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Abstract
The dystroglycanopathies, which are caused by reduced glycosylation of alpha-dystroglycan, are a heterogeneous group of neurodegenerative
disorders characterized by variable brain and skeletal muscle involvement. Recently, mutations in TMEM5 have been described in severe
dystroglycanopathies. We present the clinical, molecular and neuroimaging features of an Italian boy who had delayed developmental milestones
with mild limb-girdle muscle involvement, bilateral frontotemporal polymicrogyria, moderate intellectual disability, and no cerebellar
involvement. He also presented a cochlear dysplasia and harbored a reported mutation (p.A47Rfs*42) in TMEM5, detected using targeted
next-generation sequencing. The relatively milder muscular phenotype and associated structural brain abnormalities distinguish this case from
previously reported patients with severe dystroglycanopathies and expand the spectrum of TMEM5-associated disorders.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).
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1. Introduction
The dystroglycanopathies are heterogeneous clinical conditions
characterized by reduced glycosylation of alpha-dystroglycan
(α-DG) in skeletal muscles [1]. Clinical presentations range
from prenatal brain malformations to congenital muscular
dystrophies (CMDs) with various combinations of ocular
involvement and mental retardation, and late-onset limb-girdle
muscular dystrophies (LGMDs) [1]. The list of disease-associated
genes has grown rapidly with the advent of next-generation
sequencing (NGS) technologies which can be combined with
protein network analysis [2], and this has significantly expanded
the spectrum of clinical phenotypes [3].
TMEM5 encodes a transmembrane protein thought to be
involved in the glycosylation of dystroglycan [2]. Mutations in
TMEM5 were initially described in three infants presenting
congenital muscle hypotonia and severe brain malformations
meeting the clinical diagnosis of Walker–Warburg syndrome
(WWS)/muscle–eye–brain disease (MEB) [2], the most severe,
rapidly lethal forms of CMD [1]. A study of an undiagnosed
cohort of fetuses with cobblestone type II lissencephaly
(cobblestone-LIS) [4], a peculiar brain malformation with
characteristic MRI abnormalities, revealed five additional
mutations.
We herein expand the phenotypic spectrum of disorders
associated with mutations in TMEM5, describing a patient who
presented repeatedly elevated CK levels and mild limb-girdle
muscular involvement, and whose NGS-based molecular
testing disclosed an already reported variant.
2. Case report
This 13-year-old boy was born to non-consanguineous
healthy parents at 38 weeks of gestation. At birth he presented
with a low birth weight (2600 g), normal head circumference
(36 cm) and respiratory distress. His neurodevelopment was
globally delayed as he had achieved the sitting position at
the age of 8 months and walked unaided at 23 months. A first
* Corresponding author. Molecular Medicine, IRCCS Stella Maris, via dei
Giacinti 2, 56128 Calambrone, Pisa, Italy. Tel.: + 39 050 886275; fax: +39 050
886247.
E-mail address: filippo3364@gmail.com (F.M. Santorelli).
http://dx.doi.org/10.1016/j.nmd.2016.05.003
0960-8966/© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/
4.0/).
Available online at www.sciencedirect.com
Neuromuscular Disorders 26 (2016) 459–461
www.elsevier.com/locate/nmd
ScienceDirect
EEG recording, ordered by the general pediatrician because
of developmental delay at the age of 14 months, showed
polymorphic slow waves but no seizures. At the age of 3 years,
medical examinations prior to surgery for undescended testis
revealed elevated serum creatine kinase (CK) levels (2054 U/L,
normal <190). Despite an improvement in his motor skills,
due to speech and psychomotor therapy, the patient underwent
a skeletal muscle biopsy at the age of 4 years because of
persistently elevated CK levels (3227 U/L) and EMG features
suggestive of a myopathy. Histochemistry showed a dystrophic
pattern with abnormal variation in fiber size, necrosis and
few scattered degenerative fibers, whereas immunofluorescent
stains for dystrophin, merosin/laminin-a2 (300 kDa antibody)
and sarcoglycans were normal (not shown). The glycosylated
forms of α-DG were not analyzed because of lack of material.
At the age of 5 years – when his weight was 24 kg (97°
percentile), height 114 cm (85°), and head circumference 50 cm
(50°) – a brain MRI showed bilateral frontotemporal
polymicrogyria (Fig. 1A–C), abnormal signals in the frontoparietal
white matter bilaterally, with a patchy, confluent appearance
(Fig. 1D–F), a dysplastic cerebellar cortex, and small subcortical
cerebellar cysts (Fig. 1G). Hypoplasia of the pons with a ventral
cleft and a dilated and dysmorphic fourth ventricle (Fig. 1H),
and also bilateral cochlear dysplasia (Fig. 1I), were also seen.
The patient attended yearly neuromuscular follow-ups,
and showed a stable clinical course. At the time of latest
Fig. 1. Brain MRI in a patient with CMD carrying a mutation in TMEM5. (A–C) Coronal, axial and sagittal FSE T2-weighted images showing bilateral frontotemporal
polymicrogyria (white arrow). (D, E) Axial FLAIR and (F) coronal FSE T2-weighted images revealing patchy, confluent frontoparietal white matter hyperintensities,
bilaterally distributed (white arrow). In F as well as in G (axial T2-weighted image) cerebellar anomalies are evident. The latter include abnormal orientation of the
cerebellar folia, an irregular gray matter-white matter junction (black arrows) and multiple small subcortical cysts in both cerebellar hemispheres (white arrow heads).
In G the cleft in the ventral pons (note the black arrow head) and an enlarged and dysmorphic fourth ventricle (star) are also evident. (H) Sagittal T1-weighted image
demonstrating hypoplasia of the pons (white arrow) and a mildly enlarged tectum (white arrow head). (I) Reconstruction of MIP 3D FIESTA image showing bilateral
cochlear dysplasia, with fusion of the middle and apical cochlear turns, suggestive of Mondini-type deformity (white arrow). R, right; L, left.
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examination when he was age 13, his growth was normal but he
revealed relatively mild symmetric proximal weakness: he was
able to walk 10 m in 6 s, to run 10 m in 3.3 s, and to rise from
the floor in 12 s. His forced vital capacity was 63% of normal
values. Ocular and cardiac evaluations were normal and there
were neither gait and trunk ataxia nor dysmetria and nystagmus.
Neuropsychological assessment revealed a moderate mental
delay with low verbal skills and slight deficits in attention, short
term working memory, and problem solving. Consistently with
the bilateral cochlear dysplasia observed on neuroimaging,
brain auditory evoked potentials revealed mild hearing
impairment, especially in the right ear.
This case was included in a group of undiagnosed muscular
dystrophy patients to be analyzed by Dystroplex, an extended
NGS testing panel able to investigate, in a single tube, the
coding regions of 93 genes linked to CMDs, LGMDs or
related diseases (see supplementary Appendix). We detected
the already described homozygous c.139delG:p.(A47Rfs*42)
in TMEM5 [2]. The mutation was confirmed by Sanger
sequencing and found to be heterozygous in the healthy parents.
Two additional predicted deleterious variants [the heterozygous
c.1654-6A>G in POMT2, described in a child with LGMD and
low α-DG [5], and the novel c.1079A>G: p.(Y360C) in DOLK]
were also detected in the patient and his father.
3. Discussion
To date, 12 patients harboring mutations in TMEM5 have
been described. Two siblings carried the homozygous
p.A47Rfs*42 mutation and had severe intellectual disability
with autistic features, microcephaly, broad-based gait, 20-fold
increased levels of serum CK, and a dystrophic pattern on
muscle biopsy. In one case, neuroimaging revealed brainstem
atrophy, dilated ventricles, widespread pachygyria and significant
white matter changes [2]. A nonsense p.R340* was detected in
the same study in an unrelated WWS newborn who had muscle
hypotonia, right microphthalmia, bilateral opaque cornea, cranial
ultrasound evidence of hydrocephalus, and occipital encephalocele,
and died at the age of 22 months [2]. Lastly, nine fetuses in
five families with cobblestone-LIS harbored different loss-of-
function changes [4].
The present case report lies at the mildest end of the possible
spectrum of TMEM5-associated disorders. Unlike previously
reported cases carrying p.A47Rfs*42, our patient showed only
mildly delayed achievement of motor milestones and neither
signs of cerebellar involvement nor microcephaly; furthermore,
he presented mild muscular weakness that involved the lower
limb-girdle muscles but did not prevent him from running or
using a bike, even though he tired quickly. The phenotype
appeared severe on brain imaging, yet resulted in only moderate
intellectual disability and the boy was able to attend school
profitably without needing a support teacher. Our data offer a
further example of the value of targeted NGS technologies in
clinical settings. The striking differences with earlier TMEM5-
related cases provide a further illustration of the fact that
clinical presentation in the dystroglycanopathies cannot be
explained solely by the specific gene mutation [6]. The question
of whether other modifiers of the α-DG glycosylation pathway
might have contributed to the milder course seen in our patient
remains unanswered.
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